Seeking Alpha

Shares of Celldex Therapeutics (CLDX +4.3%) gain today on the back of positive comments out of...

Shares of Celldex Therapeutics (CLDX +4.3%) gain today on the back of positive comments out of Cantor, calling the stock one of its top sector picks for 2013. The firm says that company has a solid pipeline, and visibility should to increase this year, mitigating the stock's risk. The firm maintains a Buy rating on the shares, but raises its price target to $13 from $9.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector